首页> 外国专利> 3,6-SUBSTITUTED 5-ARYLAMINO-1H-PYRIDINE-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS IN THE TREATMENT OF TISSUE DAMAGE OR DISEASE CAUSED BY NECROSIS OR APOPTOSIS

3,6-SUBSTITUTED 5-ARYLAMINO-1H-PYRIDINE-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS IN THE TREATMENT OF TISSUE DAMAGE OR DISEASE CAUSED BY NECROSIS OR APOPTOSIS

机译:3,6-取代的5-芳基氨基-1H-吡啶-2-酮衍生物及相关化合物,作为多聚(ADP-核糖)聚合物酶(PARP)抑制剂,用于治疗因神经衰弱或凋亡引起的组织损伤或疾病

摘要

The invention relates to compounds of formula (I), wherein R1 and R3 independently represent fluorine, methoxy, -OCF3, C2-C3-alkenyl or C1-C4-Alkyl which is optionally substituted with chlorine, methoxy or one, two or three fluorine atoms; R2 represents hydrogen, fluorine, methoxy, -OCF3, C2-C3-alkenyl or C1-C4-alkyl which is optionally substituted with chlorine, methoxy or one, two or three fluorine atoms; X represents O, S, NH or N(C1-C3-Alkyl); Ar represents unsubstituted or at least mono-substituted aryl or heteroaryl. Said compounds are inhibitors of poly(ADP-ribose)polymerase (PARP) and are used in medicaments for the treatment of a disease which is selected from the following: tissue damage resulting from cell damage or cell death based on necrosis or apoptosis, neuronally mediated tissue damage or diseases, cerebral ischaemia, head trauma, cerebral apoplexy, reperfusion damage, neurological disorders and neurodegenerative diseases, vascular accidents, cardiovascular disorders, myocardial infarction, myocardial ischaemia, experimental allergic encephalomyelitis (EAE), multiple sklerosis (MS), ischaemia related to heart-surgery, age-related macular degeneration, arthritis, Arterosclerosis, cancer, sceletal- muscle degenerative diseases resulting in replicative senescence, diabetes and diabetic myocardial diseases.
机译:本发明涉及式(I)的化合物,其中R 1和R 3独立地表示氟,甲氧基,-OCF 3,C 2 -C 3烯基或C 1 -C 4烷基,其任选地被氯,甲氧基或一个,两个或三个氟取代原子R 2代表氢,氟,甲氧基,-OCF 3,C 2 -C 3烯基或C 1 -C 4烷基,其任选地被氯,甲氧基或一个,两个或三个氟原子取代; X代表O,S,NH或N(C1-C3-烷基); Ar表示未取代的或至少单取代的芳基或杂芳基。所述化合物是聚(ADP-核糖)聚合酶(PARP)的抑制剂,并且用于治疗选自以下的疾病:神经元介导的基于坏死或凋亡的细胞损伤或细胞死亡引起的组织损伤组织损伤或疾病,脑缺血,头部创伤,脑卒中,再灌注损伤,神经系统疾病和神经退行性疾病,血管意外,心血管疾病,心肌梗塞,心肌缺血,实验性变应性脑脊髓炎(EAE),多发性硬化症(MS),缺血相关心脏手术,与年龄有关的黄斑变性,关节炎,动脉硬化,癌症,导致骨骼肌变性的疾病,导致复制性衰老,糖尿病和糖尿病性心肌病。

著录项

  • 公开/公告号IL182093B

    专利类型

  • 公开/公告日2011-02-28

    原文格式PDF

  • 申请/专利权人 SANOFI-AVENTIS DEUTSCHLAND GMBH;

    申请/专利号IL182093

  • 发明设计人

    申请日2007-03-21

  • 分类号C07Dnull/null;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:22

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号